![](https://www.investors.com/wp-content/uploads/2023/12/Stock-IntraCellularTherapies-01-shutt.jpg)
Biotech Stock Pulls Back After Earnings Report; Profits On The Horizon
Intra-Cellular Therapies (ITCI) is Thursday's pick for IBD 50 Growth Stocks To Watch as the biotech stock is in a cup-with-handle base. The pharmaceutical company beat and raised sales estimates for its one drug on the market, Caplyta. ↑ X NOW PLAYING …